Meta-Analysis Based on Clinical RCTs: The Effect of Molecular Epimerism on the Safety of Glycyrrhizic Acid

Table 2

The presentation and number of ADRs in the MI and CG groups.

ADR presentation	MI group		CG group
	Number of ADRs	Proportion (%)	Number of ADRs	Proportion (%)
Lower limb edema	3	10.71	23	20.18
Dizziness, headache	6	21.43	21	18.42
Increased blood pressure	2	7.14	20	17.54
Palpitation	5	17.86	13	11.40
Facial edema	3	10.71	16	14.04
Gastrointestinal reaction	5	17.86	8	7.02
Decreased muscle strength	2	7.14	7	6.14
Hypokalemia	1	3.57	3	2.63
Hyperkalemia	0	0.00	0	0.00
Urine occult blood	0	0.00	1	0.88
Facial flushing	0	0.00	1	0.88
Skin rash	1	3.57	1	0.88
Total	28	100.00	114	100.00